Article
Specific and Efficient Regression of Cancers Harboring KRAS Mutation by Targeted RNA Replacement.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 Feb 2017
Kim Sung Jin, Kim Ju Hyun, Yang Bitna, Jeong Jin-Sook, Lee Seong-Wook
Abstract excerpt
Mutations in the KRAS gene, which persistently activate RAS function, are most frequently found in many types of human cancers. Here, we proposed and verified a new approach against cancers harboring the KRAS mutation with high cancer selectivity and efficient anti-cancer effects based on targeted RNA replacement. To this end, trans-splicing ribozymes from Tetrahymena group I intron were developed, which can...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
